{"url_path":"/sec/nmtc/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1500198/0001213900-26-054749-index.html","accession_number":"0001213900-26-054749","cik":"0001500198","ticker":"NMTC","issuer_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1500198/0001213900-26-054749-index.html","primary_entity_key":"0001500198","primary_entity_name":"NEUROONE MEDICAL TECHNOLOGIES Corp"},"word_count":145,"has_tables":true,"body_markdown":"**Item 1A. Risk Factors**\n\n \n\nIn addition to the other\ninformation set forth elsewhere in this Report, you should carefully consider the factors discussed in Part I, Item 1A “Risk Factors”\nof the Company’s Annual Report on Form 10-K for the year ended September 30, 2025. Such factors, if they were to occur, could\ncause our actual results to differ materially from those expressed in our forward-looking statements in this Report, and materially adversely\naffect our financial condition or future results. Although we are not aware of any other factors that we currently anticipate will cause\nour forward-looking statements to differ materially from our future actual results, or materially affect the Company’s financial\ncondition or future results, additional risks and uncertainties not currently known to us or that we currently deem to be immaterial\nmight materially adversely affect our actual business, financial condition and/or operating results."}